ImageneBio, Inc.
IMA· Nasdaq
Released Jul 24, 2025, after the close
10-Q filed Jul 24, 2025, 24 days after period end · 0000950170-25-098414
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | — | $2.00M | $382.00K |
| Net Income | -$7.59M | -$6.26M | -$17.12M | -$20.49M |
| EPS Diluted | -$4.46 |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$0.28 |
| -$0.44 |
| -$0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.